Skip to content
healthcare.dev

Throat Remedy

NDC 85946-0002, Belladonna 30C, Hear sulphuris calcareum 30C, Lachesis mutus 30C, Mercurius solubilis 30C, Phytolacca decandra 30C, Ferrum phosphoricum 6X, Kali muriaticum 5X, Calcarea sulphurica 6X, Streptococcinum 200C, pellet, from JoyWell Co LLC.

Product NDC
85946-0002
Status
Listed
Labeler
JoyWell Co LLC
Dosage form
PELLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85946-0002 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ATROPA BELLADONNA30 [hp_C]/1
  • CALCIUM SULFIDE30 [hp_C]/1
  • LACHESIS MUTA VENOM30 [hp_C]/1
  • MERCUROUS NITRATE30 [hp_C]/1
  • PHYTOLACCA AMERICANA ROOT30 [hp_C]/1
  • FERRIC PHOSPHATE6 [hp_X]/1
  • POTASSIUM CHLORIDE5 [hp_X]/1
  • CALCIUM SULFATE, UNSPECIFIED FORM6 [hp_X]/1
  • STREPTOCOCCUS PYOGENES200 [hp_C]/1

Pharmacologic classes

Blood Coagulation Factor [EPC]; Calcium [CS]; Cations, Divalent [CS]; Increased Coagulation Factor Activity [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Iron [CS]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Parenteral Iron Replacement [EPC]; Phosphate Binder [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Phosphate Chelating Activity [MoA]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
85946-0002-185946000201100 PELLET in 1 VIAL (85946-0002-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 85946-0002 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85946-0002 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85946-0002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.